ArticleWorld journal of urology2018

A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model.

Johannes Falke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.